GlassScriptPhysician profile
Matthew D Laughlin
NPI 1073834826
$6,093.49
in general payments reported to CMS, 2019-2025
13 companies · $767 in 2025
The $767 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2021: $238 · 2022: $1,112 · 2023: $2,213 · 2024: $1,516 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,947 · Food and Beverage: $1,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,947.20 |
| Food and Beverage | $1,549.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,033.93 | 2019-2024 | Mako |
| Medacta USA, INC. | $1,375.19 | 2022-2023 | Amistem, Myknee, Gmk Sphere |
| Arthrex, INC. | $1,104.70 | 2024 | |
| Zimmer Biomet Holdings, INC. | $609.92 | 2025 | Mymobility Platform |
| Pylant Medical | $373.91 | 2024-2025 | |
| Sanara Medtech INC. | $175.84 | 2024 | Celleraterx |
| Next Science LLC | $130.36 | 2021 | |
| Globus Medical, INC. | $118.50 | 2022-2023 | Mini Fragment System, Proximal Humerus Strut |
| Si-Bone, INC. | $61.86 | 2022 | |
| Smith+Nephew, INC. | $42.77 | 2022-2023 | Bone Anchors With Arthroscopic Delivery System |
| Bioventus LLC | $28.86 | 2023 | Durolane |
| Vericel Corporation | $21.45 | 2023 | Maci |
| Davol INC. | $16.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Laughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.